Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 7,556 | 1,920 | 886 | 3,600 | 749 |
| Cost of Goods | 822 | 138 | N/A | N/A | N/A |
| Gross Profit | 6,734 | 1,782 | 886 | 3,600 | 749 |
| Operating Expenses | 22,620 | 21,035 | 13,582 | 11,660 | 8,156 |
| Operating Income | -15,064 | -19,115 | -12,696 | -8,060 | -7,407 |
| Interest Expense | 1,128 | 611 | 522 | 419 | 349 |
| Other Income | 2,595 | -2,396 | 1,714 | 86 | 450 |
| Pre-tax Income | -13,597 | -22,122 | -11,504 | -8,393 | -7,306 |
| Net Income Continuous | -13,597 | -22,122 | -11,504 | -8,393 | -7,306 |
| Net Income | $-13,597 | $-22,122 | $-11,504 | $-8,393 | $-7,306 |
| EPS Basic Total Ops | -0.40 | -0.81 | -0.39 | -0.33 | -0.42 |
| EPS Basic Continuous Ops | -0.40 | -0.81 | -0.40 | -0.33 | -0.42 |
| EPS Diluted Total Ops | -0.40 | -0.81 | -0.39 | -0.33 | -0.42 |
| EPS Diluted Continuous Ops | -0.40 | -0.81 | -0.40 | -0.33 | -0.42 |
| EPS Diluted Before Non-Recurring Items | -0.48 | -0.72 | N/A | N/A | N/A |
| EBITDA(a) | $-15,038 | $-19,098 | $-12,691 | $-8,073 | $-7,433 |